You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Valneva and VBI announce partnership for hepatitis B vaccine

Valneva and VBI Vaccines have announced a partnership in select European markets for the marketing and distribution of PreHevbri – the only 3-antigen hepatitis B vaccine approved in Europe.